Table 7 Promus DES vs Xience DES
From: Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
End Point | Promus (%) | Xience (%) | Reference |
|---|---|---|---|
Target lesion failure | 9.1 | 9.3 | [47] |
Cardiac death | 2.6 | 3.5 | |
Myocardial infarction | 3.4 | 3.2 | |
Target vessel failure | 13.1 | 12.4 | |
Stent thrombosis | 0.8 | 0.7 |